Skip to main content
. Author manuscript; available in PMC: 2024 Mar 27.
Published in final edited form as: Diabetes Res Clin Pract. 2022 Sep 27;192:110095. doi: 10.1016/j.diabres.2022.110095

Table 2.

Multivariable associations between achievement of the weight loss goal and cardiovascular outcomes, adjusting for age, sex, randomization arm, and race/ethnicity or SES, with examination interactions between arm and race/ethnicity.

Multivariable Models of Race/Ethnicity
Outcome 7 % Weight Loss Goal 1 yr
4p MACE
Mortality
Model Model 1 Model 2 Model 1 Model 2 Model 1 Model 2

Intercept 0.03 (0.01, 0.05), p < 0.001 0.03 (0.01, 0.05), p < 0.001
Age 1.02 (1.01, 1.03), p < 0.001 1.02 (1.01, 1.03), p < 0.001 1.06 (1.04, 1.07), p < 0.001 1.06 (1.04, 1.07), p < 0.001 1.08 (1.07, 1.10), p < 0.001 1.08 (1.07, 1.10), p < 0.001
Sex: Male 0.96 (0.82, 1.12), p = 0.619 0.96 (0.82, 1.12), p = 0.616 1.97 (1.69, 2.29), p = 0 1.96 (1.69, 2.28), p = 0 1.57 (1.26, 1.95), p < 0.001 1.57 (1.26, 1.95), p < 0.001
Insulin use 0.86 (0.70, 1.04), p = 0.126 0.86 (0.70, 1.04), p = 0.126 1.42 (1.20, 1.68), p < 0.001 1.42 (1.20, 1.68), p < 0.001 1.82 (1.44, 2.30), p < 0.001 1.82 (1.44, 2.30), p < 0.001
Arm: ILI 18.09 (15.07, 21.85), p < 0.001 17.35 (14.1, 21.51), p < 0.001 0.98 (0.85, 1.13), p = 0.792 0.95 (0.81, 1.12), p = 0.567 0.89 (0.72, 1.10), p = 0.292 0.94 (0.74, 1.19), p = 0.592
Race/ethnicity (ref = White)
 Black 0.54 (0.44, 0.67), p < 0.001 0.45 (0.24, 0.76), p = 0.006 0.92 (0.74, 1.13), p = 0.424 0.75 (0.55, 1.03), p = 0.074 0.91 (0.66, 1.24), p = 0.532 0.92 (0.60, 1.41), p = 0.705
 Hispanic 0.75 (0.60, 0.93), p = 0.011 0.67 (0.38, 1.1), p = 0.135 0.75 (0.59, 0.97), p = 0.025 0.85 (0.61, 1.17), p = 0.315 0.76 (0.53, 1.10), p = 0.141 0.91 (0.58, 1.44), p = 0.692
Arm by Race/Ethnicity Interactions
 ILI * Black 1.25 (0.70, 2.39), p = 0.467 1.46 (0.96, 2.22), p = 0.075 0.96 (0.52, 1.77), p = 0.904
 ILI * Hispanic 1.15 (0.66, 2.10), p = 0.645 0.76 (0.46, 1.26), p = 0.289 0.62 (0.29, 1.34), p = 0.225

Multivariable Models of Educational Attainment
Outcome 7 % Weight Loss Goal 1 yr
4p MACE
Mortality
Model Model 1 Model 2 Model 1 Model 2 Model 1 Model 2

Intercept 0.02 (0.01, 0.05), p < 0.001 0.01 (0, 0.03), p < 0.001
Age 1.02 (1.01, 1.04), p < 0.001 1.02 (1.01, 1.04), p < 0.001 1.06 (1.04, 1.07), p < 0.001 1.06 (1.05, 1.07), p < 0.001 1.09 (1.07, 1.10), p < 0.001 1.09 (1.07, 1.10), p < 0.001
Sex: Male 1.03 (0.88, 1.21), p = 0.682 1.03 (0.88, 1.21), p = 0.705 2.06 (1.77, 2.39), p < 0.001 2.06 (1.77, 2.39), p < 0.001 1.62 (1.30, 2.02), p < 0.001 1.62 (1.30, 2.02), p < 0.001
Insulin use 0.83 (0.68, 1.01), p = 0.067 0.83 (0.68, 1.01), p = 0.067 1.39 (1.17, 1.64), p < 0.001 1.39 (1.18, 1.65), p < 0.001 1.79 (1.42, 2.26), p < 0.001 1.79 (1.42, 2.26), p < 0.001
Arm: ILI 17.71 (14.76, 21.37), p < 0.001 61.82 (24.12, 210.62), p < 0.001 0.98 (0.85, 1.14), p = 0.823 0.82 (0.39, 1.73), p = 0.604 0.9 (0.73, 1.11), p = 0.316 0.36 (0.12, 1.14), p = 0.082
EA (Ref = Less than HS degree)
 HS Degree 0.72 (0.50, 1.03), p = 0.075 1.75 (0.63, 6.19), p = 0.323 1.51 (0.99, 2.29), p = 0.054 1.22 (0.68, 2.19), p = 0.502 1.13 (0.63, 2.03), p = 0.692 0.69 (0.33, 1.44), p = 0.321
 Some College 0.70 (0.51, 0.98), p = 0.035 2.17 (0.87, 7.27), p = 0.141 1.61 (1.09, 2.38), p = 0.016 1.59 (0.94, 2.70), p = 0.086 1.36 (0.80, 2.32), p = 0.257 1.00 (0.53, 1.89), p = 0.99
 College Degree or higher 0.85 (0.62, 1.18), p = 0.335 2.61 (1.06, 8.67), p = 0.067 1.3 (0.88, 1.92), p = 0.187 1.14 (0.67, 1.94), p = 0.628 1.15 (0.67, 1.96), p = 0.619 0.8 (0.43, 1.52), p = 0.501
Arm by EA Interactions
 ILI * HS Degree 0.26 (0.07, 0.70), p = 0.016 1.52 (0.66, 3.52), p = 0.327 3.42 (0.94, 12.46), p = 0.062
 ILI * Some College 0.35 (0.09, 1.05), p = 0.079 1.03 (0.47, 2.23), p = 0.947 2.33 (0.71, 7.68), p = 0.164
 ILI * College Degree or higher 0.26 (0.07, 0.70), p = 0.015 1.30 (0.60, 2.83), p = 0.503 2.60 (0.79, 8.52), p = 0.116

Model 1 = adjusted for age, sex, baseline insulin use, randomization arm, and exposure (either race/ethnicity or educational attainment).

Model 2 = adjusted for age, sex, baseline insulin use, randomization arm, exposure (either race/ethnicity or educational attainment), and arm-by-exposure (either race/ethnicity or educational attainment) interactions.

4p MACE = four-point major adverse cardiovascular events (death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for angina); EA = educational attainment; ILI = intensive lifestyle intervention; HS = high school.